Novartis has more than 50 production sites worldwide, which focus on making and delivering life-changing, quality medicines for our patients. We ensure an uninterrupted supply of over 70 billion treatments to patients each year, in more than 140 countries.
Cover of the 2022 Novartis in Society Integrated Report, Van Lacour, prostate cancer patient living in Natchez, Louisiana, who received a Novartis radioligand therapy

Transforming manufacturing

The Novartis in Society Integrated Report 2022 describes how our manufacturing operations are evolving as we embrace operational excellence.

Our leadership

Steffen Lang, Ph.D., President, Operations
President, Operations
Steffen Lang, Ph.D.


Quality is a key priority in every aspect of our work. Our patients are relying on us to deliver the highest quality standards, and we are committed to living up to their expectations.

Learn More